HCPCS code J0712: Injection, ceftaroline fosamil, 10 mg (Teflaro)

Key takeaways

HCPCS code J0712 bills injection of ceftaroline fosamil (Teflaro), and one unit equals 10 mg administered.

The adult dose is 600 mg every 12 hours for both approved indications, which bills 60 units per infusion.

A renal-adjusted dose changes the unit count, so 400 mg bills 40 units and 200 mg bills 20.

Medicaid and many commercial payers reject the whole line when the 11-digit NDC is missing.

Medicare Part B pays J0712 at ASP plus 6%, and CMS refreshes that rate every quarter.

HCPCS code J0712 bills injection of ceftaroline fosamil, the antibiotic sold as Teflaro, in 10 mg increments. One unit equals 10 mg, so a standard adult dose of 600 mg bills as 60 units.

That conversion is the most common place a J0712 claim goes wrong, and a missing NDC is the second. Payers reject both before a human reviewer opens the file, so you rebill instead of appealing.

What follows is the unit math and the renal-adjusted doses that change it. Then come the NDC format payers expect and the diagnosis codes that carry medical necessity.

J0712 covers one drug, in 10 mg increments

J0712 is the CMS HCPCS Level II code for injection of ceftaroline fosamil, 10 mg. Ceftaroline fosamil is a fifth-generation cephalosporin, marketed as Teflaro by AbbVie. It is one of the few beta-lactam antibiotics active against methicillin-resistant Staphylococcus aureus (MRSA), which is why it turns up in infusion suites at all.

The FDA approved Teflaro for two indications: community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI).

Bill J0712 only when the drug treats one of those. Off-label coverage varies widely by payer, so get it confirmed in writing before the infusion rather than after.

Medicare pays ASP plus 6%, and the rate moves every quarter

Medicare Part B reimburses J0712 at ASP plus 6% under Section 1847A of the Social Security Act. CMS builds the average sales price (ASP) from manufacturer-reported sales data and republishes it four times a year. Any dollar figure printed in a reference guide is therefore stale within a quarter.

Check the current allowable in the CMS Physician Fee Schedule lookup tool or the quarterly ASP pricing files before you submit. Rates also vary by Medicare Administrative Contractor (MAC) jurisdiction, so use the file that matches yours.

Buy-and-bill is the usual pathway for this drug. The practice buys Teflaro from a wholesaler, administers it, then bills Part B for the drug and the administration separately.

That means the practice carries the acquisition cost until the claim pays. Margin depends entirely on what you negotiated against the published ASP.

Document acquisition costs carefully, and raise anti-kickback questions with compliance counsel early. Practices that manage buy-and-bill as a margin play attract scrutiny they do not need.

When the remittance lands, compare what was paid against the ASP-based allowable you expected. A shortfall usually points at a unit miscalculation or a MAC-specific fee schedule adjustment, and both are worth catching in the same week.

Divide the dose by 10 to get your unit count

One unit of J0712 is 10 mg of ceftaroline fosamil administered. The adult dose is 600 mg every 12 hours for both approved indications, so one infusion bills 60 units. There is no adult regimen at 600 mg every 8 hours, whatever an older crosswalk may still say.

Bill the dose that went into the patient, not the vial size. Draw a 600 mg vial, infuse 400 mg, and the line reads 40 units. You can document and claim wastage under payer-specific policy, but the billed quantity always has to match the administration record.

Renal impairment changes the dose, so it changes the units

Adults with a creatinine clearance (CrCl) at or below 50 mL/min get a reduced dose, and the unit count drops with it. This is the detail that catches billers who key 60 units out of habit. The label sets three reduced regimens, all still given every 12 hours.

Kidney function can also move mid-course, which moves the unit count with it. Pull the ordered dose from the medication administration record for every date of service rather than assuming the standard 600 mg.

A worked example, from order to claim line

Take a 62-year-old admitted for CABP with a CrCl of 38 mL/min. The order reads 400 mg IV every 12 hours for six days. Each infusion bills J0712 at 40 units, alongside the infusion administration code.

Six days at two infusions a day is 12 administrations and 480 units in total. Those units belong on the dates of service they were given, one line per date. Rolling a whole course onto a single line is a fast way to trigger a medical review.

The NDC has to match the vial you actually used

Medicaid requires a national drug code (NDC) on every J0712 claim line, and many commercial payers do too. It goes on the drug line in 11-digit format behind the N4 qualifier. The Teflaro 600 mg single-dose vial carries NDC 0456-0600-01, which submits as N4 00456060001.

Teflaro ships as a lyophilized powder in 400 mg and 600 mg single-dose vials, and the two sizes carry different NDCs. Read the number off the carton you opened instead of a saved default. Labelers renumber packages when manufacturing or distribution changes, so check the current Teflaro listing on DailyMed when a carton looks unfamiliar.

Leave the NDC off a payer that wants it and the claim rejects rather than denies. A rejection never enters adjudication, so there is nothing to appeal. You correct the line and resubmit, while the timely-filing clock keeps running.

Modifiers and diagnosis codes decide whether the line pays

Two fields decide whether a J0712 line clears adjudication. One is the modifier on the drug line, the other is the diagnosis behind it. Payers edit them separately, so both have to hold up on their own.

JW and JZ are the modifiers that matter here

Medicare wants one of the two discarded-drug modifiers on every J0712 line drawn from a single-dose vial. Which one you use depends on whether anything was thrown away.

• JW, drug amount discarded. Append it when part of a single-dose vial is wasted, and record both the amount used and the amount discarded.
• JZ, zero drug amount discarded. Append it when the full vial went into the patient. Medicare expects JZ wherever JW does not apply.
• GY, item or service statutorily excluded. Use it when you bill a non-covered service so it can move on to a secondary payer or to patient responsibility.
• GA, waiver of liability on file. Use it when you expect a medical-necessity denial and hold a signed advance beneficiary notice (ABN).

Payers differ on which of these they accept. Confirm against your MAC’s local coverage determination (LCD) and the individual contract before you append one.

The diagnosis has to match an approved indication

Every J0712 line needs at least one ICD-10-CM code that supports an FDA-approved indication and matches the chart. These are the codes that show up most often on Teflaro claims.

The CABP indication on the Teflaro label covers methicillin-susceptible S. aureus isolates, so J15.211 is the specific pneumonia code that fits. A MAC’s LCD can also cover a narrower list than the label allows, and those lists change on an annual cycle.

Check your jurisdiction before you submit, and keep the ICD-10-CM code library open when documentation names an organism the payer wants coded precisely.

Documentation is what survives a post-payment audit

Recoupment after payment costs more than a front-end denial, because the money has already been spent. Reviewers ask for the same five things when they pull a Teflaro claim.

• A confirmed diagnosis. Culture results or clinical findings supporting CABP or ABSSSI, recorded on or before the date of service.
• Treatment rationale. A note explaining why ceftaroline was chosen, and its MRSA activity where that drove the decision.
• The administration record. Dose in mg, route, date, start and stop times, and the clinician who gave it.
• Step-therapy evidence. Where a payer requires it, proof that first-line agents failed or were contraindicated.
• The prior authorization number. If the plan required approval, the number belongs on the claim itself.

For a practice running repeated outpatient ABSSSI courses, a templated infusion note pays for itself quickly. Capture the diagnosis, the ordered dose, the administered dose, and the rationale in the same place every time.

Check prior authorization before the infusion is booked

Medicare Part B fee-for-service generally does not require prior authorization for drugs given under buy-and-bill. Medicare Advantage and commercial plans frequently do, and each Advantage plan sets its own formulary. Approval from fee-for-service tells you nothing about the Advantage plan sitting next to it.

Verify eligibility and the plan’s authorization rules before you put the infusion on the schedule. Then confirm that the approved ICD-10 code appears on the authorization, not just the drug name. A clean claim line for J0712 carries the code, the units, the NDC, the administration CPT code, and the authorization number together.

Walk the claim through in this order

The data elements are the same on a CMS-1500 and a UB-04. What matters is the order you assemble them in, because that is what keeps the dose, the units, and the NDC from drifting apart.

1. Confirm the dose administered. Pull the administration record and divide the milligrams by 10.
2. Enter J0712 with that unit count. Never round up, and never substitute vial size for the dose given.
3. Add the NDC in N4 format. Eleven digits on the drug line, required for Medicaid and verified per commercial payer.
4. Pair it with the administration code. Use 96365 for the initial hour of IV infusion, and 96366 for each additional hour.
5. Attach the diagnosis code. It must reflect an approved indication and appear on your MAC’s covered list.
6. Include the authorization number. Put it in the claim field the payer specifies, not in a note.
7. Append JW or JZ. Back JW with a wastage entry in the medical record.

Run this check before you submit

• Ordered dose and administered dose match the medication administration record.
• Unit count equals the administered milligrams divided by 10.
• NDC sits on the drug line, 11 digits, behind the N4 qualifier.
• JW or JZ is present, and JW is backed by a wastage note.
• The diagnosis code appears on your MAC’s covered list for this drug.
• The authorization number is on the claim wherever the plan required one.

Four errors that stall J0712 claims

• Billing the vial instead of the dose. A 600 mg vial with 400 mg infused is 40 units.
• Keying 60 units by habit. A reduced renal dose bills a reduced count, and no clearinghouse edit will catch it for you.
• Rolling a multi-day course onto one line. Each infusion is its own date of service.
• Dropping the NDC on a commercial payer that wants it. That returns as a rejection, and the filing clock keeps running.

When one does slip through, read the remittance before you resubmit. The denial codes returned on the 835 tell you whether the problem was the unit count, the diagnosis, or the authorization.

How Pabau keeps J0712 claim lines complete

Billing teams usually assemble a J0712 line from three places at once. The dose comes from the infusion note, the NDC comes from the carton, and the authorization number comes from the payer portal. Re-keying across three windows is where a 60 quietly becomes a 6.

Practice management software like Pabau keeps those pieces on one record instead. Pabau’s medical claims management pulls the treatment note, the patient’s insurance details, and the coded charge straight into the claim. Code lookup libraries mean the biller selects J0712 from a stored list rather than typing it from memory.

A completeness check then runs before submission and flags any required field left empty, so the line does not leave the practice half-built. Unit counts and modifier choices stay with the biller, where they belong. Pabau’s job is getting a complete claim out the door on the day the infusion happened.

Build drug claim lines once, not three times

Pabau’s claims management keeps the treatment note, insurance details and coded charge on one record. A completeness check then flags missing required fields before the claim reaches the payer.

Book a demo

Conclusion

J0712 rewards a boring habit. Read the ordered dose off the administration record, divide by 10, and copy the NDC off the carton you opened. Do that on every infusion and unit errors stop appearing on your remittance.

The renal-adjusted doses are the part worth writing down somewhere visible. A patient whose kidney function shifts mid-course shifts the unit count too, and no clearinghouse edit will flag that. It falls to the biller who reads the chart.

Practices that keep the note, the charge, and the insurance details in one system spend less time chasing the pieces of a drug claim. Book a demo and we will walk a J0712 line through Pabau from infusion note to submitted claim.

Continue your research

Need to understand how denials affect your J-code revenue? Denial management in healthcare covers the most common denial patterns and how to build a systematic appeal workflow.

Want a reference for the codes on your remittance? Denial codes in medical billing explains the CARC and RARC codes that come back most often on drug claims.

Not sure what makes a claim pass first time? What is a clean claim sets out the fields payers check before a claim ever reaches adjudication.

Building charge capture for infusion visits? Superbill shows what belongs on the encounter form so the drug and the administration both get billed.

Looking for a primer on how the billing cycle works? Revenue cycle management walks through every stage from charge capture to payment posting.

Frequently asked questions